Latest Breaking News On - Cadila healthcare limited - Page 1 : vimarsana.com

China Medical System: New Drug Application of Desidustat Tablets Accepted in China – IT Business Net

China Medical System: New Drug Application of Desidustat Tablets Accepted in China

Zydus Lifesciences introduces new drug in US markets

According to IQVIA MAT data, Mirabegron extended-release tablets (USP 25mg and 50mg) had yearly sales of USD 2.42 billion in the United States.

China Medical System: New Drug Application of Desidustat

SHENZHEN, CHINA, April 23, 2024 (GLOBE NEWSWIRE) Desidustat Tablets are novel, oral HIF-PHI for treating anaemia in non-dialysis adult chronic kidney.

China Medical System: New Drug Application of Desidustat Tablets Accepted in China

Moti Mahal vs Daryaganj: Who invented butter chicken? Delhi HC to decide

Both Moti Mahal and Daryaganj claim to be associated with the ‘inventor’ of butter chicken. With Moti Mahal filing a trademark violation suit against Daryaganj, all eyes are on the Delhi High Court.

Hypolipidemics Market Size, Share, Revenue, Trends And Drivers For 2024-2033

Daewoong Pharmaceutical : and Zydus Announce Exclusive Licensing Agreement for Development and Commercialization of Leuprolide Long-Acting Injectable in the U.S. -December 11, 2023 at 12:25 am EST

2023-1211 Daewoong Pharmaceutical and Zydus Announce Exclusive Licensing Agreement for Development and Commercialization of Leuprolide Long-Acting Injectable in the U.S. .

Opioid Drugs Market to Surpass $56.5 billion by 2030:

Opioid drugs are prescribed to relieve severe pain and are highly addictive. Some key products include oxycodone, hydrocodone, codeine, morphine etc. .